[1] Afifi A, El Setouhy M, El Sharkawy M, et al. Diabetic nephropathy as a cause of end-stage renal disease in Egypt: a six-year study[J]. East Mediterr Health J, 2004, 10(4-5): 620-626.
[2] Lenz E M, Bright J, Wilson I D, et al. Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects[J]. J Pharm Biomed Anal, 2004, 36(4): 841-849.
[3] Kirschenlohr H L, Griffin J L, Clarke S C, et al. Proton NMR analysis of plasma is a weak predictor of coronary artery disease[J]. Nat Med, 2006, 12(6): 705-710.
[4] Feng Yue(冯越), Zhang Xu(张许), Liu Maili (刘买利). Dynamic changes of regional metabolic profiles in chick embryo brain during development studied by an NMR-based metabonomic approach(代谢组学方法分析鸡胚发育过程中脑代谢物)[J]. Chinese J Magn Reson(波谱学杂志), 2009, 26(1): 27-36.
[5] Dong Ai-sheng(董爱生), Tian Jian-ming(田建明), Lu Jian-ping(陆建平), et al. Metabolic profiles in human hepatic tumors analyzed by in vitro high-resolution magic-angle-spinning 1H NMR spectroscopy(肝脏肿瘤高分辨魔角旋转质子波谱分析) [J]. Chinese J Magn Reson(波谱学杂志), 2009, 26(1): 51-57.
[6] Barba I, Jaimez-Auguets E, Rodriguez-Sinovas A, et al. 1H NMR-based metabolomic identification of at-risk areas after myocardial infarction in swine[J]. Magma, 2007, 20(5-6): 265-271.
[7] Makinen V P, Soininen P, Forsblom C, et al. 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death[J]. Mol Syst Biol, 2008, 4: 167-178.
[8] Salek R M, Maguire M L, Bentley E, et al. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human[J]. Physiol Genomics, 2007, 29(2): 99-108.
[9] Sharma K, McCue P, Dunn S R. Diabetic kidney disease in the db/db mouse[J]. Am J Physiol Renal Physiol, 2003, 284(6): 1 138-1 144.
[10] Makinen V P, Soininen P, Forsblom C, et al. Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum[J]. Magma, 2006, 19(6): 281-296.
[11] Zhang D, Yang H, Kong X, et al. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes[J]. Am J Physiol Endocrind Metab, 2010, Epub ahead of print.
[12] Xu J, Zhang J, Cai S, et al. Metabonomics studies of intact hepatic and renal cortical tissues from diabetic db/db mice using highresolution magic-angle spinning 1H NMR spectroscopy[J]. Anal Bioanal Chem, 2009, 393(6-7): 1 657-1 668.
[13] Jonsson P, Bruce S J, Moritz T, et al. Extraction, interpretation and validation of information for comparing samples in metabolic LC/MS data sets[J]. Analyst, 2005, 130(5): 701-707.
[14] Westerhuis J A, Hoefsloot H C J, Smit S, et al. Assessment of PLSDA cross validation[J]. Metabolomics, 2008, 4: 81-89.
[15] Zhao X, Fritsche J, Wang J, et al. Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits
[J]. Metabolomics, 2010. Epub ahead of print. DOI: 10.1007/s11306-010-0203-1.
[16] Serkova N, Fuller T F, Klawitter J, et al. 1H NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants[J]. Kidney Int, 2005, 67(3): 1 142-1 151.
[17] Hauet T, Baumert H, Gibelin H, et al. Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury[J]. Cryobiology, 2000, 41(4): 280-291.
[18] Leon C A, Raij L. Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy[J]. J Hypertens, 2005, 23(11): 1 931-1 937.
[19] Allen T J, Cooper M E, Lan H Y. Use of genetic mouse models in the study of diabetic nephropathy[J]. Curr Diab Rep, 2004, 4(6): 435-440.
[20] Zakaria F A. Effect of oxygen derived free radicals and glycine on sodium-potassium adenosine triphosphatase in the basolateral membrane of the kidney in ischemia-reperfusion[J]. Saudi Med J, 2002, 23(11): 1 380-1 385.
[21] Jones G L, Sang E, Goddard C, et al. A functional analysis of mouse models of cardiac disease through metabolic profiling[J]. J Biol Chem, 2005, 280(9): 7 530-7 539.
[22] Pan Z, Gu H, Talaty N, et al. Principal component analysis of urine metabolites detected by NMR and DESI-MS in patients with inborn errors of metabolism[J]. Anal Bioanal Chem, 2007, 387(2): 539-549.
[23] Antoine D J, Mercer A E, Williams D P, et al. Mechanism-based bioanalysis and biomarkers for hepatic chemical stress[J]. Xenobiotica, 2009, 39(8): 565-577. |